• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与心房和心室心律失常及猝死的非典型表型相关的新型突变的生物物理特征

Biophysical Characterization of a Novel Mutation Associated With an Atypical Phenotype of Atrial and Ventricular Arrhythmias and Sudden Death.

作者信息

Ghovanloo Mohammad-Reza, Atallah Joseph, Escudero Carolina A, Ruben Peter C

机构信息

Department of Biomedical Physiology and Kinesiology, Faculty of Science, Simon Fraser University, Burnaby, BC, Canada.

Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

出版信息

Front Physiol. 2020 Dec 22;11:610436. doi: 10.3389/fphys.2020.610436. eCollection 2020.

DOI:10.3389/fphys.2020.610436
PMID:33414724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7783455/
Abstract

BACKGROUND

Sudden cardiac death (SCD) is an unexpected death that occurs within an hour of the onset of symptoms. Hereditary primary electrical disorders account for up to 1/3 of all SCD cases in younger individuals and include conditions such as catecholaminergic polymorphic ventricular tachycardia (CPVT). These disorders are caused by mutations in the genes encoding cardiac ion channels, hence they are known as cardiac channelopathies. We identified a novel variant, T1857I, in the C-terminus of Nav1.5 () linked to a family with a CPVT-like phenotype characterized by atrial tachy-arrhythmias and polymorphic ventricular ectopy occurring at rest and with adrenergic stimulation, and a strong family history of SCD.

OBJECTIVE

Our goal was to functionally characterize the novel Nav1.5 variant and determine a possible link between channel gating and clinical phenotype.

METHODS

We first used electrocardiogram recordings to visualize the patient cardiac electrical properties. Then, we performed voltage-clamp of transiently transfected CHO cells. Lastly, we used the ventricular/atrial models to visualize gating defects on cardiac excitability.

RESULTS

Voltage-dependences of both activation and inactivation were right-shifted, the overlap between activation and inactivation predicted increased window currents, the recovery from fast inactivation was slowed, there was no significant difference in late currents, and there was no difference in use-dependent inactivation. The O'Hara-Rudy model suggests ventricular after depolarizations and atrial Grandi-based model suggests a slight prolongation of atrial action potential duration.

CONCLUSION

We conclude that T1857I likely causes a net gain-of-function in Nav1.5 gating, which may in turn lead to ventricular after depolarization, predisposing carriers to tachy-arrhythmias.

摘要

背景

心源性猝死(SCD)是指症状发作后一小时内发生的意外死亡。遗传性原发性心电疾病在年轻个体的所有SCD病例中占比高达1/3,包括儿茶酚胺能多形性室性心动过速(CPVT)等病症。这些疾病由编码心脏离子通道的基因突变引起,因此被称为心脏离子通道病。我们在Nav1.5()的C末端鉴定出一种新的变异体T1857I,该变异体与一个具有CPVT样表型的家族相关,其特征为静息时及肾上腺素能刺激下出现房性快速心律失常和多形性室性早搏,且有强烈的SCD家族史。

目的

我们的目标是对新的Nav1.5变异体进行功能特性分析,并确定通道门控与临床表型之间的可能联系。

方法

我们首先使用心电图记录来观察患者的心脏电特性。然后,对瞬时转染的CHO细胞进行电压钳实验。最后,我们使用心室/心房模型来观察心脏兴奋性的门控缺陷。

结果

激活和失活的电压依赖性均向右移位,激活与失活之间的重叠预测窗口电流增加,快速失活后的恢复减慢,晚期电流无显著差异,使用依赖性失活也无差异。奥哈拉 - 鲁迪模型提示心室后去极化,基于格兰迪的心房模型提示心房动作电位持续时间略有延长。

结论

我们得出结论,T1857I可能导致Nav1.5门控功能净增益,进而可能导致心室后去极化,使携带者易患快速心律失常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/98ad3e496e48/fphys-11-610436-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/8126bc7a41b8/fphys-11-610436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/5f455ebacbd5/fphys-11-610436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/8d7b37f350b8/fphys-11-610436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/3c2d00c7a9ce/fphys-11-610436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/56278c019afa/fphys-11-610436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/98ad3e496e48/fphys-11-610436-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/8126bc7a41b8/fphys-11-610436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/5f455ebacbd5/fphys-11-610436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/8d7b37f350b8/fphys-11-610436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/3c2d00c7a9ce/fphys-11-610436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/56278c019afa/fphys-11-610436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d504/7783455/98ad3e496e48/fphys-11-610436-g006.jpg

相似文献

1
Biophysical Characterization of a Novel Mutation Associated With an Atypical Phenotype of Atrial and Ventricular Arrhythmias and Sudden Death.与心房和心室心律失常及猝死的非典型表型相关的新型突变的生物物理特征
Front Physiol. 2020 Dec 22;11:610436. doi: 10.3389/fphys.2020.610436. eCollection 2020.
2
Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.SCN5A功能获得性突变导致室性心律失常和早发性心房颤动。
Int J Cardiol. 2017 Jun 1;236:187-193. doi: 10.1016/j.ijcard.2017.01.113. Epub 2017 Jan 29.
3
Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.SCN5A基因的功能获得性突变会导致运动诱发的多形性室性心律失常。
Circ Cardiovasc Genet. 2014 Dec;7(6):771-81. doi: 10.1161/CIRCGENETICS.114.000703. Epub 2014 Sep 10.
4
SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.阻断成纤维细胞生长因子同源因子调控的SCN5A变体导致人类心律失常。
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12528-33. doi: 10.1073/pnas.1516430112. Epub 2015 Sep 21.
5
Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.胺碘酮反应性多灶性室性早搏相关心肌病中的新型SCN5A突变
Heart Rhythm. 2014 Aug;11(8):1446-53. doi: 10.1016/j.hrthm.2014.04.042. Epub 2014 May 9.
6
Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.携带钠通道SCN5A D1275N突变个体的心电图变化和房性心律失常。
Ann Med. 2017 Sep;49(6):496-503. doi: 10.1080/07853890.2017.1307515. Epub 2017 Apr 17.
7
Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na1.5 gain-of-function mutation (G213D).由 Na1.5 功能获得性突变(G213D)引起的多发性房性和室性早搏,伴有扩张型心肌病风险增加。
Int J Cardiol. 2018 Apr 15;257:160-167. doi: 10.1016/j.ijcard.2017.11.095.
8
A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.苯妥英钠通过独特的分子机制挽救新型长 QT3 变异。
J Mol Cell Cardiol. 2020 Jul;144:1-11. doi: 10.1016/j.yjmcc.2020.04.027. Epub 2020 Apr 24.
9
In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant.伴有房室传导阻滞及自发或利多卡因诱发室性心动过速的长QT综合征宫内发病:人ether-à-go-go相关基因(hERG)孔区突变与心脏钠通道基因(SCN5A)N端变异的复合效应
Heart Rhythm. 2008 Nov;5(11):1567-74. doi: 10.1016/j.hrthm.2008.08.010. Epub 2008 Aug 17.
10
SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.SCN5A(K817E),一种与Brugada综合征相关的新型突变,可改变NaV1.5通道的激活门控。
Heart Rhythm. 2016 May;13(5):1113-1120. doi: 10.1016/j.hrthm.2016.01.008. Epub 2016 Jan 8.

引用本文的文献

1
Functionally-selective inhibition of threshold sodium currents and excitability in dorsal root ganglion neurons by cannabinol.大麻酚对背根神经节神经元阈钠电流和兴奋性的功能选择性抑制。
Commun Biol. 2024 Jan 23;7(1):120. doi: 10.1038/s42003-024-05781-x.
2
Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol.非精神活性植物大麻素与电压门控钠通道的相互作用:大麻二酚和大麻萜酚的最新进展。
Front Physiol. 2022 Nov 10;13:1066455. doi: 10.3389/fphys.2022.1066455. eCollection 2022.
3
Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

本文引用的文献

1
Cannabidiol interactions with voltage-gated sodium channels.大麻二酚与电压门控钠离子通道的相互作用。
Elife. 2020 Oct 22;9:e58593. doi: 10.7554/eLife.58593.
2
Say Cheese: Structure of the Cardiac Electrical Engine Is Captured.《说茄子:心脏电引擎结构被捕获》。
Trends Biochem Sci. 2020 May;45(5):369-371. doi: 10.1016/j.tibs.2020.02.003. Epub 2020 Feb 24.
3
Cannabidiol protects against high glucose-induced oxidative stress and cytotoxicity in cardiac voltage-gated sodium channels.大麻二酚可保护心脏电压门控钠通道免受高糖诱导的氧化应激和细胞毒性作用。
儿科人群遗传性致心律失常疾病的临床遗传学
Biomedicines. 2022 Jan 5;10(1):106. doi: 10.3390/biomedicines10010106.
4
Clinical Spectrum of Channelopathy in Children with Primary Electrical Disease and Structurally Normal Hearts.原发性心电疾病且心脏结构正常患儿中的通道病的临床谱。
Genes (Basel). 2021 Dec 22;13(1):16. doi: 10.3390/genes13010016.
5
Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Na1.4 in Its Slow-Inactivated State and Inhibits Sodium Current.大麻二酚在其慢失活状态下选择性结合电压门控钠通道Na1.4并抑制钠电流。
Biomedicines. 2021 Sep 2;9(9):1141. doi: 10.3390/biomedicines9091141.
6
Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications.大麻二酚与钠离子通道药理学:概述、机制及临床意义。
Neuroscientist. 2022 Aug;28(4):318-334. doi: 10.1177/10738584211017009. Epub 2021 May 24.
7
Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity.大麻二酚通过阻塞其孔道和改变膜弹性来抑制骨骼肌 Nav1.4。
J Gen Physiol. 2021 May 3;153(5). doi: 10.1085/jgp.202012701.
Br J Pharmacol. 2020 Jul;177(13):2932-2946. doi: 10.1111/bph.15020. Epub 2020 Mar 10.
4
Structure of the Cardiac Sodium Channel.心脏钠离子通道的结构。
Cell. 2020 Jan 9;180(1):122-134.e10. doi: 10.1016/j.cell.2019.11.041. Epub 2019 Dec 19.
5
Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome.近期对于遗传性原发心律失常综合征中临床测序和基于基因的风险分层的认识。
J Cardiol. 2019 May;73(5):335-342. doi: 10.1016/j.jjcc.2019.01.009. Epub 2019 Mar 23.
6
Inhibitory effects of cannabidiol on voltage-dependent sodium currents.大麻二酚对电压依赖性钠离子电流的抑制作用。
J Biol Chem. 2018 Oct 26;293(43):16546-16558. doi: 10.1074/jbc.RA118.004929. Epub 2018 Sep 14.
7
Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na1.5 gain-of-function mutation (G213D).由 Na1.5 功能获得性突变(G213D)引起的多发性房性和室性早搏,伴有扩张型心肌病风险增加。
Int J Cardiol. 2018 Apr 15;257:160-167. doi: 10.1016/j.ijcard.2017.11.095.
8
Catecholaminergic polymorphic ventricular tachycardia, an update.儿茶酚胺能性多形性室性心动过速,最新进展。
Ann Noninvasive Electrocardiol. 2018 Jul;23(4):e12512. doi: 10.1111/anec.12512. Epub 2017 Oct 19.
9
The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on I.iPSC-CMs 的不成熟电生理表型仍然阻碍了体外药物筛选:特别关注 I.
Pharmacol Ther. 2018 Mar;183:127-136. doi: 10.1016/j.pharmthera.2017.10.001. Epub 2017 Oct 3.
10
The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.儿茶酚胺多形性室性心动过速的临床和遗传谱:来自国际多中心注册研究的结果。
Europace. 2018 Mar 1;20(3):541-547. doi: 10.1093/europace/euw389.